JLL: Life Sciences sector thriving; accounts for nearly 30% of leases signed in N.J. during 2024

ROI-NJ

Factuality

Ownership

JLL: Life Sciences sector thriving; accounts for nearly 30% of leases signed in N.J. during 2024

New Jersey’s life sciences arena was active in 2024, as a broad spectrum of companies pursued office, R&D/lab, and bio manufacturing opportunities. In fact, a new report from JLL shows that nearly 30% of leases signed in the state during the past year involved pharmaceutical/life sciences companies, which was the largest volume of activity among the various business sectors. This was also the third consecutive year in which life sciences was the…